BioCryst to Present at Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following investor conferences:
Related news for (BCRX)
- Breaking News: MoBot’s Latest Update as of 05/05/25 03:00 PM
- Today’s Top Performers: MoBot’s Market Review 05/05/25 02:00 PM
- BioCryst Pharmaceuticals Soars with Stellar Q1 2025 Results, Raises ORLADEYO Guidance, and Achieves Profitability Ahead of Schedule
- BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
- BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting